Trending Articles

article thumbnail

Opinion: Medicaid cuts would devastate mental health, substance use treatment services in red states

STAT

When House Republicans voted in the wee hours of the morning of May 22 to cut approximately $700 billion from Medicaid , they moved one step closer to rendering dangerously vulnerable the millions of Medicaid recipients struggling with mental illness and substance use disorder. Medicaid, which covers more than 72 million Americans, is the single largest payer of behavioral health services , which includes mental health and substance use disorder treatment.

331
331
article thumbnail

It’s Code Red for Vaccines in America

NY Times

Skip to content Skip to site index Today’s Paper Opinion | It’s Code Red for Vaccines [link] Share full article 205 205 Advertisement SKIP ADVERTISEMENT You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load. Opinion Supported by SKIP ADVERTISEMENT Guest Essay It’s Code Red for Vaccines June 11, 2025, 5:03 a.m.

Vaccines 126
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

The biggest obesity deals of 2025 so far

PharmaVoice

Skip to main content CONTINUE TO SITE ➞ Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve

article thumbnail

Takeda presents positive results from trial of chronic kidney disease treatment

Pharmafile

Takeda Pharmaceuticals has announced positive results from a proof-of-concept study of mezagitamab (TAK-079) to treat patients with primary immunoglobulin A nephropathy (IgAN), a chronic kidney disease. The Japanese biopharma is now looking ahead to a prospective phase 3 trial of mezagitamab. The data was presented at the European Renal Association Congress on 6 June 2025 […] The post Takeda presents positive results from trial of chronic kidney disease treatment appeared first on Pharmafi

116
116
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Sarah Huckabee Sanders: Republicans Can Lead on This Health Care Issue

NY Times

Pharmacy benefit managers have used anti-competitive practices to dominate the prescription drug market.

95
article thumbnail

Pharmacists can apply for educational funding for their family

The Pharmacist

Community pharmacists, pharmacy technicians, their spouses or children could benefit from up to £5,000 in university educational grants and bursaries from a charity. Independent education charity, Leverhulme Trade Charities Trust (LTCT), provides financial aid for those working in the pharmacy, convenience, grocery trades and is offering £3,000 a year for undergraduate and £5,000 a year […] The post Pharmacists can apply for educational funding for their family appeared first on The Pharma

More Trending

article thumbnail

The former Wall Street analyst shaping Novartis’ big-picture strategy

PharmaVoice

Ronny Gal, chief strategy and growth officer at Novartis, is guiding the company into a new era shaped by science-minded M&A and a slimmed-down pivot.

130
130
article thumbnail

Implications of RFK Jr.’s CDC Vaccine Committee Overhaul for the Pharmaceutical Industry

PharmaTech

News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer

article thumbnail

Italfarmaco’s Duvyzat gains EC conditional approval for DMD treatment

Pharmaceutical Business Review

Duvyzat must be administered alongside corticosteroids and is not limited by the patient’s specific genetic mutation. The decision is applicable across all 27 EU member states, as well as Iceland, Liechtenstein, and Norway. Following a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) in April 2025, this approval marks a significant milestone.

83
article thumbnail

Beyfortus now has a direct rival after FDA OK for Enflonsia

pharmaphorum

MSD could soon enter the US market for drugs used to protect infants from RSV infections, setting up a rivalry with AstraZeneca/Sanofi's Beyfortus

100
100
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Opinion: We have ‘post-vaccination syndrome.’ We are tired of being used to score anti-vax points

STAT

We recently went viral. Well, not exactly us — but people like us. We are participants in the Yale LISTEN Study , a patient-centered study to better understand long Covid and the adverse effects some patients have experienced post Covid-vaccination. We are members of the post-vaccination cohort, a group that includes more than 250 patients.

Vaccines 353
article thumbnail

Pharmacists are well placed to take the lead on ear health

The Pharmacist

Access to ear and hearing healthcare is becoming increasingly challenging. According to RNID, four in ten patients wait longer than six weeks on average for an audiology assessment. In addition, the postcode lottery of wax removal services in the UK is leading to dangerous self-management. Hearing loss is far more than just a minor inconvenience […] The post Pharmacists are well placed to take the lead on ear health appeared first on The Pharmacist.

article thumbnail

Navigating Complex Regulatory Environments in Drug Portfolio Management

Drug Patent Watch

"Navigating the Maze of Regulations: How Pharmaceutical Companies Can Safeguard Their Drug Portfolios As the pharmaceutical industry continues to evolve, regulatory environments are becoming increasingly complex. With new laws and guidelines emerging regularly, companies must stay agile to avoid costly delays and maintain market competitiveness.

article thumbnail

Levicept presents new LEVI-04 data at EULAR

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Levicept presents new LEVI-04 data at EULAR by John Pinching | 12th Jun 2025 | News Biotech firm shares phase 2 findings on novel osteoarthritis treatmen Levicept has presented new data from its phase 2 trial of LEVI-04 at the European Congress of Rheumatology (EULAR 2025).

118
118
article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

MAHA-friendly bill in Texas would put warning labels on foods with any of 44 additives

STAT

Europe’s comparatively cautious approach to food additives is the envy of health secretary Robert F. Kennedy Jr. and the Make America Healthy Again movement. A Texas bill now before Gov. Greg Abbott aims to help close the gap by slapping warning labels on foods that contain any of 44 additives and dyes. Abbott has not said whether he intends to sign Senate Bill 25 into law.

Labelling 241
article thumbnail

FDA clears Nuvation's first product Ibtrozi, for lung cancer

pharmaphorum

Nuvation is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment for ROS1-positive lung cancer.

76
article thumbnail

Episode 1034: Pharmacy Considerations When Managing Caustic Ingestion

Pharmacy Joe

In this episode, I’ll discuss things a pharmacist should keep in mind when managing a patient with a caustic ingestion. Episode 1034: Pharmacy Considerations When Managing Caustic Ingestion Subscribe on iTunes , Android , or Stitcher According to an article in Intensive Care Medicine, caustic or corrosive ingestion in adult patients is a rare but potentially life-threatening condition with a mortality of 10% among intensive care unit (ICU) patients.

article thumbnail

Data cleaning and harmonisation: A catalyst for innovation

Express Pharma

Scientific discovery has always relied on good, clean data. Bad data leads to ir- reproducible outcomes, prob- lematic solutions, and, ultimately, the need to revisit and acquire better data. Now that AI-driven predictive models are becoming more commonplace in early drug discovery workflows, the importance of data that is ac- curate and consistent across en- tire research workflows has never been greater.

article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Tagomics secures £860k grant for colorectal cancer test

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Tagomics secures £860k grant for colorectal cancer test by John Pinching | 10th Jun 2025 | News Biotech firm to collaborate with NHS on early detection study Tagomics has been awarded £860k in funding from Innovate UK’s Biomedical Catalyst programme to develop a novel diagnostic test for colorectal cance

95
article thumbnail

NIH walks back ban on new grants for universities with DEI programs or Israel boycotts

STAT

The National Institutes of Health has, for now, walked back a policy requiring universities and other research institutes to certify that they do not have unlawful diversity, equity, and inclusion programs or boycotts of Israel in order to receive research dollars.  The rule, which was initially posted in April , was seen as the next stage of using research funds as leverage against private universities and efforts to increase diversity in the sciences.

335
335
article thumbnail

Novo Nordisk teams up with NVIDIA on AI models

pharmaphorum

Novo Nordisk and tech giant NVIDIA have joined forces on a new project that aims to speed up drug discovery using generative AI.

98
article thumbnail

Can ‘reputational pull’ save biotech from pharma’s image problem?

PharmaVoice

A reputation is tough to build and easy to bruise. For drugmakers stuck in reputational limbo, embracing a clear direction and forward-thinking strategy can foster a rosier image.

130
130
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

CII Telangana to host “Pillars of Protection”conference on pharma and chemical safety

Express Pharma

The Confederation of Indian Industry (CII), Telangana, has announced the “Pillars of Protection – Forging a Safer Future for Pharma and Chemical Manufacturing” conference, which is scheduled to take place on 25th June 2025 in Hyderabad. The event is positioned as a strategic forum for stakeholders across the pharmaceutical and chemical sectors, including industry leaders, regulators, safety experts, and operational heads.

59
article thumbnail

How to check if a drug is patented?

Drug Patent Watch

The Secret to Unlocking Affordable Medication: A Simple 3-Step Guide to Checking if Your Prescription is Tied Up in Patent Red Tape As the cost of prescription medication continues to skyrocket, it's more crucial than ever to understand the complex world of pharmaceutical patents. But do you know if the medication you're taking is protected by a patent?

73
article thumbnail

Opinion: I’m adopted. I still won’t use genetic testing services like 23andMe

STAT

As an adoptee who was placed in foster care at 18 months old, I’ve never known my full racial heritage, family tree, or medical history. People have often suggested I try 23andMe or a similar company to get more information on my genetics. But I’ve always felt uneasy about it. So, I felt a little vindicated when I saw the news that Regeneron Pharmaceuticals is set to acquire 23andMe , including its troves of customer data, for $256 million.

246
246
article thumbnail

US lawmakers seek ban on DTC advertising

pharmaphorum

US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by the pharma industry.

66
article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.

article thumbnail

Pharmacy must grow as ‘key clinical provider’, says NHSE primary care lead

The Pharmacist

Community pharmacy must ‘grow’ as a ‘key clinical service provider’ within primary care, NHS England’s national director for primary care and community services has suggested. Speaking at the NHS Confed Expo healthcare conference in Manchester on Wednesday, Dr Amanda Doyle said she recognised that community pharmacy felt ‘underwater currently’ but that she wanted its clinical […] The post Pharmacy must grow as ‘key clinical provider’, says NHSE primary care lead appeared first on The Pharm

article thumbnail

Vaccine makers face fresh uncertainty after firing of CDC panel

BioPharma Dive

The abrupt termination of the 17 panelists guiding the CDC’s vaccine recommendations could yield a new committee more aligned with Robert F. Kennedy Jr.’s skeptical views, analysts warned.

Vaccines 113
article thumbnail

Investigational treatment shows promise for aggressive multiple myeloma

Pharma Times

Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership Jobs Investigational treatment shows promise for aggressive multiple myeloma by John Pinching | 16th Jun 2025 | News Results suggest bispecific antibody combination could improve outcomes A new investigational treatment has shown strong and lasting responses in multiple myeloma patients with extramedullary di

65
article thumbnail

STAT+: A closer look at the new members of the CDC vaccine advisory panel

STAT

For more than a half-century, the Centers for Disease Control and Prevention has relied on outside experts to guide the agency’s recommendations on how vaccines should be used to prevent the spread of infectious disease. That task will now fall to a panel that includes several individuals who’ve either been openly critical of vaccines or who have scant infectious disease expertise.

Vaccines 308
article thumbnail

5 Reasons to Upgrade Your Pharmacy Management Software

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.